You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 146 No. 10, October 1986 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL INVESTIGATIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Hypercalcemia and Elevated Calcitriol in a Maintenance Dialysis Patient With Tuberculosis

Arnold J. Felsenfeld, MD; Marc K. Drezner, MD; Francisco Llach, MD

Arch Intern Med. 1986;146(10):1941-1945.


Abstract

• A patient on maintenance hemodialysis had widely disseminated tuberculosis, hypercalcemia, and elevated levels of calcitriol (1,25-dihydroxycholecalciferol). Hypercalcemia was not observed until the eighth month of hemodialysis, when persistent fevers began. At the end of a calcium-free dialysis, the plasma calcium concentration decreased to 6.6 mg/dL (1.65 mmol/L). The baseline calcitriol level was 56 pg/mL (normal, 19 to 50 pg/mL and increased to 147 pg/mL at the end of hemodialysis. Parathyroid hormone levels by three separate assays did not appreciably increase during the hypocalcemia Induced by the calcium-free hemodialysis. The serum phosphate concentration decreased from 7.3 to 4.5 mg/dL (2.36 to 1.45 mmol/L). Extrarenal production of calcitriol may occur in disseminated tuberculosis and may be stimulated by hypocalcemia and reduced serum phosphate. The expected parathyroid hormone response to hypocalcemia may have been inhibited by persistently elevated calcitriol levels or preexisting hypercalcemia.

(Arch Intern Med 1986;146:1941-1945)



Author Affiliations

From the Department of Medicine, University of Oklahoma Health Sciences Center and the Veterans Administration Medical Center (Drs Felsenfeld and Llach), Oklahoma City; and the Department of Medicine, Duke University Medical Center (Dr Drezner), Durham, NC.


Footnotes

Accepted for publication Jan 22, 1986.

Reprint requests to 111G, Veterans Administration Medical Center, 921 NE 13th St, Oklahoma City, OK 73104 (Dr Felsenfeld).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Tuberculosis and the Kidney
EASTWOOD et al.
J. Am. Soc. Nephrol. 2001;12:1307-1314.
FULL TEXT  

Severe hypercalcaemia with normal serum calcitriol in a diabetic patient with chronic renal failure, autoimmune hepatitis and disseminated tuberculosis
Yen et al.
Nephrol Dial Transplant 2000;15:2046-2049.
FULL TEXT  

Ketoconazole Decreases the Serum Ionized Calcium and 1,25-Dihydroxyvitamin D Levels in Tuberculosis-Associated Hypercalcemia
Saggese et al.
Arch Pediatr Adolesc Med 1993;147:270-273.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1986 American Medical Association. All Rights Reserved.